Eversept Partners LP Decreases Stock Position in Anteris Technologies Global Corp. $AVR

Eversept Partners LP trimmed its holdings in Anteris Technologies Global Corp. (NASDAQ:AVR) by 19.8% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 401,187 shares of the company’s stock after selling 98,813 shares during the period. Eversept Partners LP owned 0.41% of Anteris Technologies Global worth $2,227,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in the business. Deutsche Bank AG raised its position in Anteris Technologies Global by 8.1% during the fourth quarter. Deutsche Bank AG now owns 28,865 shares of the company’s stock worth $144,000 after acquiring an additional 2,171 shares during the last quarter. Bank of America Corp DE grew its position in shares of Anteris Technologies Global by 35.7% in the third quarter. Bank of America Corp DE now owns 10,631 shares of the company’s stock valued at $48,000 after purchasing an additional 2,798 shares during the last quarter. Russell Investments Group Ltd. grew its position in shares of Anteris Technologies Global by 76.9% in the third quarter. Russell Investments Group Ltd. now owns 6,536 shares of the company’s stock valued at $29,000 after purchasing an additional 2,841 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its stake in shares of Anteris Technologies Global by 35.2% during the 2nd quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 11,744 shares of the company’s stock worth $45,000 after purchasing an additional 3,055 shares in the last quarter. Finally, Barclays PLC increased its stake in shares of Anteris Technologies Global by 3.0% during the 4th quarter. Barclays PLC now owns 148,128 shares of the company’s stock worth $739,000 after purchasing an additional 4,289 shares in the last quarter.

Anteris Technologies Global Price Performance

Anteris Technologies Global stock opened at $8.17 on Tuesday. Anteris Technologies Global Corp. has a 12-month low of $2.99 and a 12-month high of $11.06. The stock has a market capitalization of $795.27 million, a P/E ratio of -3.66 and a beta of 1.65. The firm’s 50-day moving average is $9.27 and its two-hundred day moving average is $7.07.

Anteris Technologies Global (NASDAQ:AVR) last posted its quarterly earnings data on Tuesday, May 12th. The company reported ($0.28) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.27) by ($0.01). The firm had revenue of $0.49 million during the quarter, compared to analyst estimates of $0.77 million. Anteris Technologies Global had a negative net margin of 5,148.78% and a negative return on equity of 124.76%. During the same period in the prior year, the firm earned ($0.61) EPS. As a group, analysts forecast that Anteris Technologies Global Corp. will post -1.14 EPS for the current year.

Insider Activity at Anteris Technologies Global

In other Anteris Technologies Global news, Director Susan Elizabeth Knight acquired 11,000 shares of the stock in a transaction dated Tuesday, June 2nd. The stock was acquired at an average price of $9.29 per share, with a total value of $102,190.00. Following the completion of the transaction, the director directly owned 11,000 shares in the company, valued at approximately $102,190. This trade represents a ? increase in their ownership of the stock. The purchase was disclosed in a document filed with the SEC, which is available at the SEC website. 4.50% of the stock is currently owned by corporate insiders.

Wall Street Analysts Forecast Growth

AVR has been the subject of several research reports. Weiss Ratings restated a “sell (d-)” rating on shares of Anteris Technologies Global in a research report on Friday, May 29th. Wall Street Zen upgraded Anteris Technologies Global from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Finally, Barclays raised their price target on Anteris Technologies Global from $17.00 to $18.00 and gave the stock an “overweight” rating in a research report on Friday, May 15th. Four research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the company. According to MarketBeat, Anteris Technologies Global currently has an average rating of “Moderate Buy” and a consensus price target of $16.00.

Anteris Technologies Global Company Profile

Anteris Technologies Global Corp. engages in the development and commercialization of medical devices for heart diseases. The company was founded in 1999 and is headquartered in Eagan, MN.